Skip to main content
. 2022 Mar 3;36(2):1035–1040. doi: 10.21873/invivo.12799

Figure 1. Computed tomography (upper panels) and positron-emission tomography-CT (lower panels) of the target lesion (yellow arrows) in axial and coronal planes before photoimmunotherapy. A: The lesion extended from the periphery of the lateral pterygoid muscle to the base of the skull, 8×18 mm, with a maximum standard uptake value=13.03. B: The superficial lesion on the posterior wall of the maxillary sinus was 10×8 mm.

Figure 1